U.S. health advisers have endorsed kid-size doses of Pfizer's COVID-19 vaccine for younger children.
WASHINGTON — A panel of U.S. health advisers on Tuesday endorsed kid-size doses of Pfizer’s COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11.
While children are at lower risk of severe COVID-19 than older people, 5- to 11-year-olds still have faced substantial illness ― including over 8,300 hospitalizations reported, about a third requiring intensive care, and nearly 100 deaths. In a preliminary analysis last week, Food and Drug Administration reviewers said that protection would “clearly outweigh” the risk of a very rare side effect in almost all scenarios of the pandemic. Now FDA’s advisers are combing through that data to see if they agree.If the FDA authorizes the kid-size doses, there’s still another step: Next week, the Centers for Disease Control and Prevention will have to decide whether to recommend the shots and which youngsters should get them.
“I want to acknowledge the fact that there are strong feelings” among the public for and against child vaccinations, Marks added, noting that the discussion would be on scientific data “not about vaccine mandates, which are left to other entities outside of FDA.” Pfizer’s study tracked 2,268 children ages 5 to 11 who got two shots three weeks apart of either a placebo or the kid dose. Vaccinated youngsters developed levels of virus-fighting antibodies just as strong as teens and young adults who got the full-strength shots.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
COVID-19 live updates: FDA panel hours away from vote on Pfizer vaccine for kidsAn independent FDA advisory panel will debate and vote on whether to authorize the Pfizer vaccine for children ages 5 to 11. The nonbinding vote is expected between 4:30 p.m. and 5 p.m. ET today.
Les mer »
U.S. FDA advisers weigh Pfizer/BioNTech COVID-19 vaccine in childrenAn expert panel will weigh authorization of Pfizer Inc and BioNTech's COVID-19 vaccine for U.S. children aged 5 to 11 on Tuesday as it prepares to vote on a recommendation for the federal Food and Drug Administration.
Les mer »
Pfizer CEO says company will produce 4 billion COVID-19 doses in 2022Pfizer CEO Albert Bourla says the company is increasing its output to meet global demand.
Les mer »
FDA advisors review Pfizer’s COVID-19 vaccine for younger kidsU.S. health advisors are debating whether kid-size doses of Pfizer's COVID-19 vaccine are safe and effective in young children ages 5 to 11.
Les mer »
U.S. has administered nearly 414 mln doses of COVID-19 vaccinesThe United States has administered 413,645,478 doses of COVID-19 vaccines in the country as of Sunday morning and distributed 503,493,015 doses, the U.S. Centers for Disease Control and Prevention said.
Les mer »
U.S. has administered nearly 414 million doses of COVID-19 vaccinesThe number of doses administered is up from 412,856,169 vaccine doses the CDC said had gone into arms by Saturday. The CDC has previously said that revisions made by vaccine providers can result in cumulative delivery data dropping between certain days. The CDC did not immediately respond to a request for comment.
Les mer »